Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Synergistic enhancement of tenogenic differentiation in adipose-derived stem cells via TGF-β and laser therapy.

Mpanza M., Abrahamse H., Crous A.

Laboratory Study on Tendon Injury, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Front Bioeng Biotechnol (2026)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
42453138
DOI
10.3389/fbioe.2026.1860498

Abstract (original English)

Adipose-derived stem cells (ADSCs) are increasingly explored for tendon regeneration owing to their accessibility and multipotency. Low-level laser therapy (LLLT), also referred to as Photobiomodulation (PBM), has emerged as a promising non-invasive approach for modulating cellular behavior. However, directing their differentiation into tenocytes remains an ongoing focus of optimization. This study investigates the synergistic effects of transforming growth factor-beta (TGF-β) and PBM on the tenogenic differentiation of ADSCs. ADSCs were cultured and exposed to specific PBM wavelengths (525 nm, 825 nm, and consecutive irradiation) at 5 and 10 J/cm 2 , both in the presence and absence of TGF-β. Tenogenic differentiation was evaluated using morphological assessments, gene expression analysis of key tenogenic markers (SCX, TNC, COL1A1, COL3A1, and DCN), morphology changes, and biochemical assays. The results reveal that PBM, especially at 525 nm and 5 J/cm 2 , in conjunction with TGF-β, significantly enhances tenogenic gene expression, ECM protein deposition, and cellular alignment indicative of tenocyte phenotype. These findings support a promising dual-modality approach to enhance ADSC tenogenic commitment and inform future tendon tissue engineering strategies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research